Cargando…

Advancing Adjuvants for Mycobacterium tuberculosis Therapeutics

Tuberculosis (TB) remains one of the leading causes of death worldwide due to a single infectious disease agent. BCG, the only licensed vaccine against TB, offers limited protection against pulmonary disease in children and adults. TB vaccine research has recently been reinvigorated by new data sugg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Enriquez, Ana B., Izzo, Angelo, Miller, Shannon M., Stewart, Erica L., Mahon, Robert N., Frank, Daniel J., Evans, Jay T., Rengarajan, Jyothi, Triccas, James A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572789/ https://www.ncbi.nlm.nih.gov/pubmed/34759923 http://dx.doi.org/10.3389/fimmu.2021.740117

Ejemplares similares

High Frequencies of Caspase-3 Expressing Mycobacterium tuberculosis-Specific CD4(+) T Cells Are Associated With Active Tuberculosis
por: Adekambi, Toidi, et al.
Publicado: (2018)

Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity
por: Stewart, Erica, et al.
Publicado: (2019)

Role of Fused Mycobacterium tuberculosis Immunogens and Adjuvants in Modern Tuberculosis Vaccines
por: Junqueira-Kipnis, Ana Paula, et al.
Publicado: (2014)

Characterizing Early T Cell Responses in Nonhuman Primate Model of Tuberculosis
por: Sharan, Riti, et al.
Publicado: (2021)

Characterizing the BCG Induced Macrophage and Neutrophil Mechanisms for Defense Against Mycobacterium tuberculosis
por: Bickett, Thomas E., et al.
Publicado: (2020)

Innate Immune Defenses in Human Tuberculosis: An Overview of the Interactions between Mycobacterium tuberculosis and Innate Immune Cells
por: Sia, Jonathan Kevin, et al.
Publicado: (2015)

Correction: Stewart et al. Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity. Microorganisms 2019, 7, 255
por: Stewart, Erica, et al.
Publicado: (2022)

Engaging the CD40-CD40L pathway augments T-helper cell responses and improves control of Mycobacterium tuberculosis infection
por: Sia, Jonathan Kevin, et al.
Publicado: (2017)

Recent Advances in Defining the Immunoproteome of Mycobacterium tuberculosis
por: Kunnath-Velayudhan, Shajo, et al.
Publicado: (2013)

Mycobacterium tuberculosis impedes CD40-dependent notch signaling to restrict Th(17) polarization during infection
por: Enriquez, Ana Beatriz, et al.
Publicado: (2022)

Immunity to Mycobacterium tuberculosis
por: Triccas, James A., et al.
Publicado: (2011)

Distinct Effector Memory CD4(+) T Cell Signatures in Latent Mycobacterium tuberculosis Infection, BCG Vaccination and Clinically Resolved Tuberculosis
por: Adekambi, Toidi, et al.
Publicado: (2012)

Cyclic di-AMP as endogenous adjuvant enhanced BCG-induced trained immunity and protection against Mycobacterium tuberculosis in mice
por: Ning, Huanhuan, et al.
Publicado: (2022)

Delta inulin-based adjuvants promote the generation of polyfunctional CD4(+) T cell responses and protection against Mycobacterium tuberculosis infection
por: Counoupas, Claudio, et al.
Publicado: (2017)

Mechanisms of Control of Mycobacterium tuberculosis by NK Cells: Role of Glutathione
por: Allen, Michael, et al.
Publicado: (2015)

Analysis of stress- and host cell-induced expression of the Mycobacterium tuberculosis inorganic pyrophosphatase
por: Triccas, James A, et al.
Publicado: (2001)

Is Receptor-Interacting Protein Kinase 3 a Viable Therapeutic Target for Mycobacterium tuberculosis Infection?
por: Stutz, Michael D., et al.
Publicado: (2018)

Regulatory T Cells in Mycobacterium tuberculosis Infection
por: Cardona, Paula, et al.
Publicado: (2019)

Recombinant BCG With Bacterial Signaling Molecule Cyclic di-AMP as Endogenous Adjuvant Induces Elevated Immune Responses After Mycobacterium tuberculosis Infection
por: Ning, Huanhuan, et al.
Publicado: (2019)

Recombinant BCG expressing the LTAK63 adjuvant increased memory T cells and induced long-lasting protection against Mycobacterium tuberculosis challenge in mice
por: Marques-Neto, Lázaro Moreira, et al.
Publicado: (2023)

Early innate cell interactions with Mycobacterium tuberculosis in protection and pathology of tuberculosis
por: Sankar, Poornima, et al.
Publicado: (2023)

A New Adjuvant MTOM Mediates Mycobacterium tuberculosis Subunit Vaccine to Enhance Th1-Type T Cell Immune Responses and IL-2(+) T Cells
por: Yu, Qi, et al.
Publicado: (2017)

The T-Cell Response to Lipid Antigens of Mycobacterium tuberculosis
por: De Libero, Gennaro, et al.
Publicado: (2014)

Beyond Killing Mycobacterium tuberculosis: Disease Tolerance
por: Divangahi, Maziar, et al.
Publicado: (2018)

Genetic Resistance to Mycobacterium tuberculosis Infection and Disease
por: Möller, Marlo, et al.
Publicado: (2018)

The In Vivo Transcriptomic Blueprint of Mycobacterium tuberculosis in the Lung
por: Coppola, Mariateresa, et al.
Publicado: (2021)

Uncovering the Mast Cell Response to Mycobacterium tuberculosis
por: Torres-Atencio, Ivonne, et al.
Publicado: (2022)

Persistent expression of activation markers on Mycobacterium tuberculosis-specific CD4 T cells in smear negative TB patients
por: Esmael, Ahmed, et al.
Publicado: (2022)

Novel Lipidated Imidazoquinoline TLR7/8 Adjuvants Elicit Influenza-Specific Th1 Immune Responses and Protect Against Heterologous H3N2 Influenza Challenge in Mice
por: Miller, Shannon M., et al.
Publicado: (2020)

Mechanism of activation of porcine dendritic cells by an α-D-glucan nanoparticle adjuvant and a nanoparticle/poly(I:C) combination adjuvant
por: Hernandez-Franco, Juan F., et al.
Publicado: (2022)

A Mycobacterium tuberculosis Specific IgG3 Signature of Recurrent Tuberculosis
por: Fischinger, Stephanie, et al.
Publicado: (2021)

Mycobacterium tuberculosis Invasion of the Human Lung: First Contact
por: Maertzdorf, Jeroen, et al.
Publicado: (2018)

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
por: Sharan, Riti, et al.
Publicado: (2018)

Immunity to the Dual Threat of Silica Exposure and Mycobacterium tuberculosis
por: Konečný, Petr, et al.
Publicado: (2019)

The Roles of Host Noncoding RNAs in Mycobacterium tuberculosis Infection
por: Wei, Li, et al.
Publicado: (2021)

Therapeutic efficacy against Mycobacterium tuberculosis using ID93 and liposomal adjuvant formulations
por: Baldwin, Susan L., et al.
Publicado: (2022)

Preventive effects of Mycobacterium tuberculosis DNA vaccines on the mouse model with latent tuberculosis infection
por: Liang, Yan, et al.
Publicado: (2023)

Mycobacterium tuberculosis Hip1 Modulates Macrophage Responses through Proteolysis of GroEL2
por: Naffin-Olivos, Jacqueline L., et al.
Publicado: (2014)

MPL Adjuvant Contains Competitive Antagonists of Human TLR4
por: Wang, Yi-Qi, et al.
Publicado: (2020)

Macrophage Polarization: Convergence Point Targeted by Mycobacterium Tuberculosis and HIV
por: Lugo-Villarino, Geanncarlo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ttmdk34snsl0ilhkot4qan10ot